Impaired clot retraction in factor XIII A subunit-deficient mice

Blood

Volumn 115, Issue 6, 2010, Pages 1277-1279

  Kasahara, Kohji ^a   Souri, Masayoshi ^b   Kaneda, Mizuho ^a   Miki, Toshiaki ^a   Yamamoto, Naomasa ^c   Ichinose, Akitada ^b  

^a TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

^b YAMAGATA UNIVERSITY   (Japan)

^c OHU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE DIPHOSPHATE; BLOOD CLOTTING FACTOR 13A; CYSTAMINE; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE ANTIBODY; COLLAGEN; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE; PROTEIN SUBUNIT;

ANIMAL EXPERIMENT; ARTICLE; BLEEDING TIME; BLOOD CLOT RETRACTION; CONTROLLED STUDY; ENZYME ACTIVITY; HEMOSTASIS; IN VIVO STUDY; KNOCKOUT MOUSE; MOUSE; NONHUMAN; PATHOLOGY; PRIORITY JOURNAL; THROMBOCYTE AGGREGATION; THROMBOCYTE FUNCTION; THROMBOCYTE RICH PLASMA; WILD TYPE; ANIMAL; BLOOD CLOTTING FACTOR 13 DEFICIENCY; C57BL MOUSE; METABOLISM; MOUSE MUTANT; PHYSIOLOGY;

ADENOSINE DIPHOSPHATE; ANIMALS; CLOT RETRACTION; COLLAGEN; FACTOR XIII DEFICIENCY; FACTOR XIIIA; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PLATELET-RICH PLASMA; PROTEIN SUBUNITS; TRANSGLUTAMINASES;

EID: 77949521779     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2009-06-227645     Document Type: Article

References (25)

1. Lorand L, Losowsky MS, Miloszewski KJ. Human factor XIII: fibrin-stabilizing factor. Prog Hemost Thromb. 1980;5:245-290.
2. Muszbek L, Adány R, Mikkola H. Novel aspects of blood coagulation factor XIII: I. Structure, distribution, activation, and function. Crit Rev Clin Lab Sci. 1996;33(5):357-421. (Pubitemid 26405375)
3. Ichinose A. Extracellular transglutaminase: factor XIII. Prog Exp Tumor Res. 2005;38:192-208.
4. Seitz R, Duckert F, Lopaciuk S, Muszbek L, Rodeghiero F, Seligsohn U. ETRO Working Party on Factor XIII questionnaire on congenital factor XIII deficiency in Europe: status and perspectives. Study Group. Semin Thromb Hemost. 1996;22(5):415-418. (Pubitemid 27050711)
5. Devine DV, Bishop PD. Platelet-associated factor XIII in platelet activation, adhesion, and clot stabilization. Semin Thromb Hemost. 1996;22(5):409-413.
6. Adány R, Bárdos H. Factor XIII subunit A as an intracellular transglutaminase. Cell Mol Life Sci. 2003;60(6):1049-1060. (Pubitemid 36791910)
7. Cohen I, Gerrard JM, White JG. Ultrastructure of clots during isometric contraction. J Cell Biol. 1982;93(3):775-787.
8. Endo Y, Takahashi K, Mamiya S, Satoh M, Matsuda M. Factor XIII deficiency associated with Klippel-Weber disease, platelet dysfunction and cryofibrinogenemia. Acta Haematol. 1983;69(6):398-403.
9. Carr ME Jr, Carr SL, Tildon T, Fisher LM, Martin EJ. Batroxobin-induced clots exhibit delayed and reduced platelet contractile force in some patients with clotting factor deficiencies. J Thromb Haemost. 2003;1(2):243-249.
10. Rao KM, Newcomb TF. Clot retraction in a factor XIII free system. Scand J Haematol. 1980;24(2):142-148.
11. Jelenska M, Kopeć M, Breddin K. On the retraction of collagen and fibrin induced by normal, defective and modified platelets. Haemostasis. 1985;15(3):169-175.
12. Niewiarowski S, Markiewicz M, Nath N. Inhibition of the platelet-dependent fibrin retraction by the fibrin stabilizing factor (FSF, factor 13). J Lab Clin Med. 1973;81(5):641-650.
13. Ozsoylu S, Hicsönmez G. Platelet aggregation in congenital factor XIII deficiency. Acta Haematol. 1976;56(5):314-317.
14. Aihara M, Sawada Y, Takami H, et al. Factor XIII is not involved in human platelet-collagen interaction. Tohoku J Exp Med. 1989;159(1):37-44.
15. Lauer P, Metzner HJ, Zettlmeissl G, et al. Targeted inactivation of the mouse locus encoding coagulation factor XIII-A: hemostatic abnormalities in mutant mice and characterization of the coagulation deficit. Thromb Haemost. 2002;88(6):967-974. (Pubitemid 36024124)
16. Koseki-Kuno S, Yamakawa M, Dickneite G, Ichinose A. Factor XIII A subunit-deficient mice developed severe uterine bleeding events and subsequent spontaneous miscarriages. Blood. 2003;102(13):4410-4412.
17. Souri M, Koseki-Kuno S, Takeda N, et al. Male-specific cardiac pathologies in mice lacking either the A or B subunit of factor XIII. Thromb Haemost. 2008;99(2):401-408.
18. Souri M, Koseki-Kuno S, Takeda N, Degen JL, Ichinose A. Administration of factor XIII B subunit increased plasma factor XIII A subunit levels in factor XIII B subunit knock-out mice. Int J Hematol. 2008;87(1):60-68.
19. De Laurenzi V, Melino G. Gene disruption of tissue transglutaminase. Mol Cell Biol. 2001;21(1):148-155.
20. Puszkin EG, Raghuraman V. Catalytic properties of a calmodulin-regulated transglutaminase from human platelet and chicken gizzard. J Biol Chem. 1985;260(29):16012-16020.
21. Dale GL, Friese P, Batar P, et al. Stimulated platelets use serotonin to enhance their retention of procoagulant proteins on the cell surface. Nature. 2002;415(6868):175-179.
22. Al-Jallad HF, Nakano Y, Chen JL, McMillan E, Lefebvre C, Kaartinen MT. Transglutaminase activity regulates osteoblast differentiation and matrix mineralization in MC3T3-E1 osteoblast cultures. Matrix Biol. 2006;25(3):135-148.
23. Cohen I, Glaser T, Veis A, Bruner-Lorand J. Ca2+-dependent cross-linking processes in human platelets. Biochim Biophys Acta. 1981; 676(2):137-147.
24. Ando Y, Imamura S, Yamagata Y, et al. Platelet factor XIII is activated by calpain. Biochem Biophys Res Commun. 1987;144(1):484-490.
25. Ono A, Westein E, Hsiao S, et al. Identification of a fibrin-independent platelet contractile mechanism regulating primary hemostasis and thrombus growth. Blood. 2008;112(1):90-99.